Synchron公司获得美国食品药品监督管理局（FDA）批准，开始对其血管内脑机接口设备进行早期可行性研究。
Synchron receives FDA approval to begin early feasibility study of their endovascular, brain-computer interface device.
作者信息
Han Jason J
出版信息
Artif Organs. 2021 Oct;45(10):1134-1135. doi: 10.1111/aor.14049. Epub 2021 Aug 19.
PMID:34414575
Abstract
Stentrode by Synchron is an endovascularly implanted brain computer interface platform that can relay the activities from the motor cortices of paralyzed patients, potentially offering a relatively noninvasive option for more than five million people in the United States alone.
摘要
Synchron公司的Stentrode是一种血管内植入式脑机接口平台，它能够传递瘫痪患者运动皮层的活动信息，仅在美国就可能为超过五百万人提供一种相对无创的选择。
Zotero 插件